SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales slipped to Rs. 96.40 millions, down -42.65% for the June 2025 quarter as against Rs. 168.10 millions during the year-ago period.The Net Loss for the quarter ended June 2025 is Rs. -520.30 millions as compared to Net Loss of Rs. -968.40 millions of corresponding quarter ended June 2024 Operating profit Margin for the quarter ended June 2025 improved to -433.10% as compared to -935.60% of corresponding quarter ended June 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 96.40 168.10 -42.65 96.40 168.10 -42.65 717.70 755.50 -5.00
Other Income 90.20 15.60 478.21 90.20 15.60 478.21 17.90 294.70 -93.93
PBIDT -433.10 -935.60 -53.71 -433.10 -935.60 -53.71 -3254.80 -3743.20 -13.05
Interest 61.80 5.20 1088.46 61.80 5.20 1088.46 89.10 16.60 436.75
PBDT -494.90 -940.80 -47.40 -494.90 -940.80 -47.40 -3343.90 -3759.80 -11.06
Depreciation 25.40 27.60 -7.97 25.40 27.60 -7.97 108.30 121.30 -10.72
PBT -520.30 -968.40 -46.27 -520.30 -968.40 -46.27 -3452.20 -3881.10 -11.05
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -520.30 -968.40 -46.27 -520.30 -968.40 -46.27 -3452.20 -3881.10 -11.05
Equity 324.50 324.50 0.00 324.50 324.50 0.00 324.50 324.50 0.00
PBIDTM(%) -449.27 -556.57 -19.28 -449.27 -556.57 -19.28 -453.50 -495.46 -8.47

Sun Pharma Adv. Res Share Price

172.85 5.90 (3.53%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 458.00
Indegene 529.65
CMS Info Systems 290.00
JITF Infralogistics 307.90
Sagility 44.18
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×